New G-FINDER report on sexual and reproductive health R&D finds new products, investments and funders required for many needs (13 August 2020)
Huge, rapid R&D scale-up to fight COVID-19 unmatched, but most new tools remain months away or longer (25 June 2020)
Funding for neglected disease research hits record high, increases for third straight year (30 January 2020)
Health Policy Watch: Most Sexual & Reproductive Health Research Financing Comes From 3 Major Donors – And COVID-19 Could Further Shrink Funding (13 August 2020)
The New Republic: Can Platform Vaccines Really Save Us? (10 August 2020)
Politico: Europe has yet to live up to its Covid-19 promises (also on Yahoo News) (7 August 2020)
Axios Science: CRISPR’s COVID push — Deforestation’s irreversible damage — Brightest fluorescent material (6 August 2020)
Le Parisien: Vaccin contre le Covid-19 : priorité aux soignants, aux personnes âgées et à risque (28 July 2020)
Le Monde: Calendrier, essais cliniques, financements: où en est-on de la course au vaccin contre le Covid-19? (27 June 2020)
Mediapart.fr: Vaccin contre le Covid-19: la toute-puissance de l’industrie pharmaceutique (22 July 2020)
LiveMint: The unprecedented race for the covid-19 vaccine, in five charts (13 July 2020)
Financial Times: Health (1 July 2020)
Research Professional News: Covid-19 R&D tops $8bn as WHO calls for new funds (29 June 2020)
The Telegraph (UK): More than $8.5bn committed to finding drugs and vaccines to fight coronavirus (26 June 2020)
Research Professional News: Covid-19 R&D: the global funding picture (19 June 2020)
STAT: First Opinion: Covid-19 has exposed the limits of the pharmaceutical market model (19 May 2020)
The Wall Street Journal: Bill Gates has regrets (11 May 2020)
Bhekisisa: Will South Africa maintain its role as top funder of health research and development? (18 March 2020)
Brookings: Preparing for pandemics such as coronavirus—will we ever break the vicious cycle of panic and neglect? (11 February 2020)
STAT: First Opinion: What record-high funding for neglected diseases doesn’t tell us about R&D for them (4 February 2020)
Forbes: Record Funding For Global Health Research, But Neglected Tropical Diseases Remain Neglected (29 January 2020)
Policy Cures Research is a global health think tank with a long and pioneering history in global health R&D data collection and analysis, securing our position as a trusted source of quality evidence within the sector. More about us
Mr. Wynne Boelt
+1 206 661 2708
wboelt [@] policycuresresearch.org